Research reveals key molecular target for colorectal cancer therapy

Research reveals key molecular target for colorectal cancer therapy

Researchers confirm safety of cancer-specific PET probe in first-in-human clinical studies "Pyruvate is known to have an important role in cancer metabolism," explains lead author of the study Dr Kenji Ohshima. "However, no one had previously studied how pyruvate produced by SRR is involved in cancer metabolism." Therefore, the researchers set out to examine what role, if any, SRR plays in the development of colorectal cancer. In a study published this month in Nature Metabolism , the researchers showed that SRR is much more abundant in colorectal cancer cells than in the surrounding tissues, and that cancer cell lines with higher levels of SRR divide at a much faster rate. Says Dr Ohshima: This was a really exciting discovery because it showed that SRR is involved in colorectal cancer cell proliferation. When we then looked more closely at the pathway as a whole, we found that pyruvate levels were decreased in a slow-growing SRR mutant colorectal cancer cell line, suggesting that the pyruvate produced by SRR enhances the proliferation of colorectal cancer cells. This result confirmed that the metabolic pathway is integral to the progression of colorectal cancer." Given the obvious importance of SRR, the researchers then decided to test whether disruption of the metabolic pathway could prevent the progression of colorectal cancer. Astonishingly, not only did inhibition of SRR halt the growth of colorectal tumors in mice, it also improved the efficacy of currently available drugs used to treat colorectal cancer, causing a significant reduction in tumor size. "There is still work to be done to confirm that our results translate into human cancer systems," explains senior author of the study Dr Eiichi Morii. "However, based on these preliminary results, we expect that future strategies targeting SRR will provide effective new therapies for the treatment of colorectal cancer." Source: Osaka University Journal reference: Ohshima, K., et al. (2020) Serine racemase enhances growth of colorectal cancer by producing pyruvate from serine. Nature Metabolism . doi.org/10.1038/s42255-019-0156-2 .



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More